10-K · February 27, 2026
Genworth repositioned around two reportable segments (Enact and Closed Block) and is investing in CareScout while returning capital to shareholders: Enact returned $407 million to Genworth Holdings in 2025 and the…
Earnings analysis · 10-Q
Filed May 6, 2026 · Our reading of the company's report
The latest report
Genworth Financial reported Q1 2026 results with increased total revenue of $1.78B and EPS of $0.28, both exceeding expectations. The Enact segment showed strong growth with a 30% increase in new insurance written,…
Genworth Financial reported Q1 2026 results with increased total revenue of $1.78B and EPS of $0.28, both exceeding expectations. The Enact segment showed strong growth with a 30% increase in new insurance written, while overall operating income fell slightly compared to the previous year. The balance sheet showed a reduction in cash and a marginal increase in assets, underscoring ongoing strategic investments in CareScout services.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Total revenue for Q1 2026 was $1.78B, a slight decrease from $1.79B in Q4 2025, driven primarily by favorable Enact segment performance.
EPS for Q1 2026 was $0.28, exceeding the estimated $0.20.
New insurance written increased 30% year-over-year to $12.79B in Q1 2026.
Net investment income rose to $766M, up 4% from Q1 2025.
Genworth Financial repurchased $66M of its shares in Q1 2026, maintaining shareholder value.
Enact's risk-to-capital ratio improved to 10.0:1, well below the maximum threshold.
Operating income decreased to $80M in Q1 2026 from $90M in Q1 2025, mainly due to increased claim expenses.
Net investment losses for Q1 2026 were reported at $(26)M, significantly down from gains of $27M in Q1 2025.
Changes in PMIERs could impact capital sufficiency in Enact's future operational performance.
Outlook deferred to earnings press release / call.
Genworth repositioned around two reportable segments (Enact and Closed Block) and is investing in CareScout while returning capital to shareholders: Enact returned $407 million to Genworth Holdings in 2025 and the…
Genworth reported Q3 2025 total revenues of $1,935 million, up $55 million (from $1,880 million) year-over-year, with income from continuing operations before income taxes of $164 million. Net income available to common…
Genworth reported quarterly revenues of $1,796 million (up $27 million vs Q2 2024) while income from continuing operations fell to $90 million (versus $111 million in Q2 2024), driving net income to $83 million (vs $110…
Genworth reported Q1 2025 total revenues of $1,786 million, down $78 million (−4.2%) from $1,864 million in Q1 2024, and diluted EPS to common shareholders declined to $0.13 (from $0.31). Operating profitability…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.